Cargando…
Regorafenib inhibited gastric cancer cells growth and invasion via CXCR4 activated Wnt pathway
AIM: Regorafenib is an oral small-molecule multi kinase inhibitor. Recently, several clinical trials have revealed that regorafenib has an anti-tumor activity in gastric cancer. However, only part of patients benefit from regorafenib, and the mechanisms of regorafenib’s anti-tumor effect need furthe...
Autores principales: | Lin, Xiao-Lin, Xu, Qi, Tang, Lei, Sun, Li, Han, Ting, Wang, Li-Wei, Xiao, Xiu-Ying |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5425213/ https://www.ncbi.nlm.nih.gov/pubmed/28489887 http://dx.doi.org/10.1371/journal.pone.0177335 |
Ejemplares similares
-
Resveratrol inhibits the growth of gastric cancer via the Wnt/β-catenin pathway
por: Dai, Hui, et al.
Publicado: (2018) -
Inhibition of the Wnt palmitoyltransferase porcupine suppresses cell growth and downregulates the Wnt/β-catenin pathway in gastric cancer
por: MO, MIN-LI, et al.
Publicado: (2013) -
DACH1 inhibits glioma invasion and tumor growth via the Wnt/catenin pathway
por: Wang, Jing, et al.
Publicado: (2018) -
DDAH1 mediates gastric cancer cell invasion and metastasis via Wnt/β‐catenin signaling pathway
por: Ye, Jianxin, et al.
Publicado: (2017) -
PRMT5 acts as a tumor suppressor by inhibiting Wnt/β-catenin signaling in murine gastric tumorigenesis
por: Tang, Yuling, et al.
Publicado: (2022)